Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

LE Reynolds, L Wyder, JC Lively, D Taverna… - Nature medicine, 2002 - nature.com
LE Reynolds, L Wyder, JC Lively, D Taverna, SD Robinson, X Huang, D Sheppard…
Nature medicine, 2002nature.com
Inhibition of αvβ3 or αvβ5 integrin function has been reported to suppress
neovascularization and tumor growth, suggesting that these integrins are critical modulators
of angiogenesis. Here we report that mice lacking β3 integrins or both β3 and β5 integrins
not only support tumorigenesis, but have enhanced tumor growth as well. Moreover, the
tumors in these integrin-deficient mice display enhanced angiogenesis, strongly suggesting
that neither β3 nor β5 integrins are essential for neovascularization. We also observed that …
Abstract
Inhibition of αvβ3 or αvβ5 integrin function has been reported to suppress neovascularization and tumor growth, suggesting that these integrins are critical modulators of angiogenesis. Here we report that mice lacking β3 integrins or both β3 and β5 integrins not only support tumorigenesis, but have enhanced tumor growth as well. Moreover, the tumors in these integrin-deficient mice display enhanced angiogenesis, strongly suggesting that neither β3 nor β5 integrins are essential for neovascularization. We also observed that angiogenic responses to hypoxia and vascular endothelial growth factor (VEGF) are augmented significantly in the absence of β3 integrins. We found no evidence that the expression or functions of other integrins were altered as a consequence of the β3 deficiency, but we did observe elevated levels of VEGF receptor-2 (also called Flk-1) in β3-null endothelial cells. These data indicate that αvβ3 and αvβ5 integrins are not essential for vascular development or pathological angiogenesis and highlight the need for further evaluation of the mechanisms of action of αv-integrin antagonists in anti-angiogenic therapeutics.
nature.com